Prestige Consumer Healthcare
279 hedge funds and large institutions have $2.49B invested in Prestige Consumer Healthcare in 2022 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 98 increasing their positions, 115 reducing their positions, and 35 closing their positions.
672% more call options, than puts
Call options by funds: $1.84M | Put options by funds: $239K
9% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 35
1.02% less ownership
Funds ownership: 101.61% → 100.59% (-1%)
2% less funds holding
Funds holding: 285 → 279 (-6)
15% less repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 115
16% less capital invested
Capital invested by funds: $2.98B → $2.49B (-$486M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nordea Investment Management
Stockholm,
Sweden
|
+$25.7M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$22.9M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$18.9M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$16.3M |
| 5 |
Jennison Associates
New York
|
+$10.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$34.8M |
| 2 |
Goldman Sachs
New York
|
-$23.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.9M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$12.3M |
| 5 |
Millennium Management
New York
|
-$9.55M |
PBH Hedge Fund Activity: Q3 2022 in Review
279 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q3 2022, worth a combined $2.49B — down 16% from $2.98B a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of PBH and 32 opened new positions — a net loss of 3 holders — while 115 trimmed existing stakes and 98 added.
The largest buyer was Nordea Investment Management, adding an estimated $25.7M. The largest seller was BlackRock, cutting an estimated $34.8M.
- 279 institutional investors held Prestige Consumer Healthcare (PBH) as of Q3 2022, down from 285 in Q2 2022.
- Funds reported $2.49B of Prestige Consumer Healthcare stock for Q3 2022, down 16% quarter-over-quarter.
- 32 funds opened new Prestige Consumer Healthcare positions in Q3 2022 and 35 closed out, a net change of -3 holders.
- The largest Prestige Consumer Healthcare buyer in Q3 2022 was Nordea Investment Management, an estimated $25.7M added.
- The largest Prestige Consumer Healthcare seller in Q3 2022 was BlackRock, an estimated $34.8M sold.
Based on aggregated 13F filings for Q3 2022.